JPMorgan Funds - Thematics - Genetic Therapies C2 Fonds
96,08
USD
+1,25
USD
+1,32
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Novartis AG Registered Shares | CH0012005267 | 3,45% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,41% |
| Sarepta Therapeutics Inc | US8036071004 | 3,31% |
| Bio-Techne Corp | US09073M1045 | 3,19% |
| Vericel Corp | US92346J1088 | 3,03% |
| Krystal Biotech Inc | US5011471027 | 3,02% |
| Amgen Inc | US0311621009 | 2,80% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 2,80% |
| Biogen Inc | US09062X1037 | 2,76% |
| Gilead Sciences Inc | US3755581036 | 2,63% |
| Sonstige | 69,60% |